Genmab
GMAB
#1369
Rank
NZ$21.41 B
Marketcap
$34.22
Share price
2.04%
Change (1 day)
-28.64%
Change (1 year)

Earnings for Genmab (GMAB)

Earnings in 2024 (TTM): NZ$2.21 Billion

According to Genmab's latest financial reports the company's current earnings are NZ$3.10 Billion. , an increase over its 2023 earnings that were of NZ$1.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Genmab from 2009 to 2024

Annual earnings

Year Earnings Change
2024 NZ$2.19 B63.99%
2023 NZ$1.33 B-17.29%
2022 NZ$1.61 B55.87%
2021 NZ$1.03 B-31.09%
2020 NZ$1.50 B111.51%
2019 NZ$0.71 B69.44%
2018 NZ$0.41 B49.63%
2017 NZ$0.28 B3.27%
2016 NZ$0.27 B46.33%
2015 NZ$0.18 B117.13%
2014 NZ$85.43 M329.17%
2013 NZ$19.9 M-159.26%
2012 -NZ$33.6 Million-48.96%
2011 -NZ$65.82 Million90.86%
2010 -NZ$34.49 Million-67.46%
2009 -NZ$0.11 Billion